News

A new stem cell treatment could eliminate the need for insulin therapy in people with type 1 diabetes, a disease where the ...
A WOMAN who’s shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker ...
The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...
An army doctor successfully saved the life of a 75-year-old man mid-flight by recognising and treating the signs of hypoglycemia, which can cause coma or even death if not treated in time. The ...
New Phase II data presented at ENDO 2025 highlight avexitide’s potential to significantly reduce severe hypoglycemic events ...
While the benefits of regular exercise are well established, it is necessary to understand whether too much intensity might ...
Amylyx Pharmaceuticals drew increased retail attention late Sunday after new clinical data presented at ENDO 2025 highlighted the potential of its lead candidate, avexitide, to significantly reduce ...
A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which ...
Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, ...
For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...
It can lead to dizziness, confusion, seizures, or even coma if not treated quickly. To help prevent this, scientists have ...
MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...